NOVARTIS AG (NVSEF)
Clinical trial NCT07249463 updates: 1. completion date: 2027-03-02 → 2027-03-23 2. primary completion date: 2027-03-02 → 2027-03-23
Clinical trial NCT07249463 updates: 1. completion date: 2027-03-02 → 2027-03-23 2. primary completion date: 2027-03-02 → 2027-03-23
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical